CN102379905A - 一种具有高效抗癌作用的含灵芝孢子油中药组合物 - Google Patents
一种具有高效抗癌作用的含灵芝孢子油中药组合物 Download PDFInfo
- Publication number
- CN102379905A CN102379905A CN2011101688123A CN201110168812A CN102379905A CN 102379905 A CN102379905 A CN 102379905A CN 2011101688123 A CN2011101688123 A CN 2011101688123A CN 201110168812 A CN201110168812 A CN 201110168812A CN 102379905 A CN102379905 A CN 102379905A
- Authority
- CN
- China
- Prior art keywords
- spore oil
- ganoderma spore
- chinese medicine
- mortierella
- weight portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 16
- 201000011510 cancer Diseases 0.000 title claims abstract description 14
- 240000008397 Ganoderma lucidum Species 0.000 title abstract description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 title abstract 3
- 241001327634 Agaricus blazei Species 0.000 claims abstract description 27
- 241000235575 Mortierella Species 0.000 claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 23
- 241000222336 Ganoderma Species 0.000 claims description 54
- 241000190633 Cordyceps Species 0.000 claims description 26
- 241000608575 Vespertilio Species 0.000 claims description 24
- 230000000694 effects Effects 0.000 claims description 17
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 12
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 6
- 229960005305 adenosine Drugs 0.000 claims description 6
- 235000010355 mannitol Nutrition 0.000 claims description 6
- 150000003648 triterpenes Chemical class 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 3
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 claims description 3
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 3
- 201000005619 esophageal carcinoma Diseases 0.000 claims description 3
- 206010017758 gastric cancer Diseases 0.000 claims description 3
- 201000011216 nasopharynx carcinoma Diseases 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 201000011549 stomach cancer Diseases 0.000 claims description 3
- 239000003560 cancer drug Substances 0.000 claims description 2
- 210000002249 digestive system Anatomy 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- 210000002345 respiratory system Anatomy 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000011160 research Methods 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 4
- 206010027476 Metastases Diseases 0.000 abstract description 3
- 230000009401 metastasis Effects 0.000 abstract description 3
- 241000233866 Fungi Species 0.000 abstract description 2
- 206010064571 Gene mutation Diseases 0.000 abstract 1
- 108700019961 Neoplasm Genes Proteins 0.000 abstract 1
- 102000048850 Neoplasm Genes Human genes 0.000 abstract 1
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000002156 mixing Methods 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 239000007901 soft capsule Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000143459 Hirsutella Species 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000009956 adenocarcinoma Diseases 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000007931 coated granule Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110168812 CN102379905B (zh) | 2011-06-22 | 2011-06-22 | 一种具有高效抗癌作用的含灵芝孢子油中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110168812 CN102379905B (zh) | 2011-06-22 | 2011-06-22 | 一种具有高效抗癌作用的含灵芝孢子油中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102379905A true CN102379905A (zh) | 2012-03-21 |
CN102379905B CN102379905B (zh) | 2013-07-24 |
Family
ID=45820006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110168812 Active CN102379905B (zh) | 2011-06-22 | 2011-06-22 | 一种具有高效抗癌作用的含灵芝孢子油中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102379905B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127184A (zh) * | 2013-03-25 | 2013-06-05 | 威海康博尔生物药业有限公司 | 一种用于提高机体免疫力、抗肿瘤的制剂 |
CN105832780A (zh) * | 2016-05-25 | 2016-08-10 | 朱国平 | 能增强人体免疫力且具有抗癌作用的药物组合物及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109394799B (zh) * | 2018-12-28 | 2021-05-28 | 南京中科药业有限公司 | 含灵芝萃取物的天然药物组合物及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559602A (zh) * | 2004-02-23 | 2005-01-05 | 南京中科生化技术有限公司 | 一种增强灵芝孢子油抗肿瘤疗效的中药 |
-
2011
- 2011-06-22 CN CN 201110168812 patent/CN102379905B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559602A (zh) * | 2004-02-23 | 2005-01-05 | 南京中科生化技术有限公司 | 一种增强灵芝孢子油抗肿瘤疗效的中药 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103127184A (zh) * | 2013-03-25 | 2013-06-05 | 威海康博尔生物药业有限公司 | 一种用于提高机体免疫力、抗肿瘤的制剂 |
CN103127184B (zh) * | 2013-03-25 | 2014-11-26 | 威海康博尔生物药业有限公司 | 一种用于提高机体免疫力、抗肿瘤的制剂 |
CN105832780A (zh) * | 2016-05-25 | 2016-08-10 | 朱国平 | 能增强人体免疫力且具有抗癌作用的药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102379905B (zh) | 2013-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bandara et al. | Polyporus umbellatus, an edible-medicinal cultivated mushroom with multiple developed health-care products as food, medicine and cosmetics: a review | |
CN106913854A (zh) | 虫草多糖蛋白肽复合物及其应用 | |
CN102754754B (zh) | 一种全燕麦型仔猪配合饲料及其制备方法 | |
CN109938332B (zh) | 一种含麦角硫因的猴头菌保健品制剂及其制备方法 | |
CN102600212B (zh) | 一种增强免疫力、辅助治疗肿瘤的医药保健品 | |
CN102488278A (zh) | 一种具有双功能保健作用的复合真菌营养液 | |
CN104479946A (zh) | 黄秋葵、菌、藻植物组合物制作营养露酒的方法 | |
CN101249259A (zh) | 一种高含量、高活性口服云芝糖肽及其制备方法和应用 | |
CN103877122A (zh) | 中药阿胶原料的生产方法及其产品 | |
CN101664180B (zh) | 一种具有保健功效的营养复合剂及其制备方法 | |
CN102379905B (zh) | 一种具有高效抗癌作用的含灵芝孢子油中药组合物 | |
CN101380346A (zh) | 一种治疗肿瘤的中药组合物及其制作方法 | |
CN104013636A (zh) | 瓦草五环三萜皂苷类化合物抗肿瘤的药物用途 | |
CN113616744A (zh) | 一种小米全谷物黄酮活性组分的制备方法和应用 | |
CN1864718A (zh) | 一种用于肿瘤辅助治疗的多糖组合物及其制剂和应用 | |
CN107412713A (zh) | 治疗自体免疫性与免疫相关性疾病的中成药、医疗食品及制备方法 | |
CN102228181B (zh) | 一种供癌症患者食用含低聚肽和壳寡糖的组合物 | |
JP2011184349A (ja) | 頻尿改善組成物、健康食品、及び血流改善組成物 | |
CN109758485A (zh) | 红菇提取物在制备治疗和/或预防肠道菌群失调症及相关疾病的制剂中的用途 | |
CN102441000B (zh) | 一种抑癌抗病口含片 | |
CN104906140A (zh) | 一种阿胶及其制备方法与相关设备 | |
CN108186794A (zh) | 一种治疗恶性肿瘤的中药组合物及其制备方法和应用 | |
CN107375509A (zh) | 一种用于提高免疫力、预防癌症的保健食品 | |
CN103463253B (zh) | 一种癌症术后防复发的真菌药物及其生产方法 | |
CN102526283A (zh) | 一种增强免疫力、缓解体力疲劳、抗肿瘤功能的保健药物配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120321 Assignee: ZHONGKE HEALTH INDUSTRY GROUP CO.,LTD. Assignor: NANJING ZHONGKE PHARMACEUTICAL Co.,Ltd. Contract record no.: 2019320000135 Denomination of invention: Ganoderma lucidum spore oil-containing Chinese medicinal composition with efficient cancer resistance Granted publication date: 20130724 License type: Common License Record date: 20190510 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a traditional Chinese medicine composition containing ganoderma lucidum spore oil with high-efficiency anticancer effect Effective date of registration: 20220105 Granted publication date: 20130724 Pledgee: Zijin Branch of Nanjing Bank Co.,Ltd. Pledgor: NANJING ZHONGKE PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980000060 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230206 Granted publication date: 20130724 Pledgee: Zijin Branch of Nanjing Bank Co.,Ltd. Pledgor: NANJING ZHONGKE PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980000060 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Chinese herbal composition containing Ganoderma spore oil with efficient anticancer effects Effective date of registration: 20231007 Granted publication date: 20130724 Pledgee: China Merchants Bank Co.,Ltd. Nanjing Branch Pledgor: NANJING ZHONGKE PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980059703 |